Impact of exercise rehabilitation on cardiac neuronal function in heart failure: An iodine-123 metaiodobenzylguanidine scintigraphy study

European Journal of Nuclear Medicine

Volumn 25, Issue 3, 1998, Pages 235-241

  Agostini, Denis ^a   Lecluse, Emmanuel ^a   Belin, Annette ^a   Babatasi, Gérard ^a   Amar, Michel Henry ^b   Grollier, Gilles ^a   Potier, Jean Claude ^a   Bouvard, Gérard ^a  

^a CHU CÔTE DE NACRE   (France)

^b CENTRE FRANÇOIS BACLESSE   (France)

Author keywords

Cardiac neuronal function; Chronic heart failure; Exercise rehabilitation; Metaiodobenzylguanidine; Scintigraphy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; RADIOISOTOPE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; EXERCISE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILITY; HEART NERVE; HEART SCINTISCANNING; HEMODYNAMICS; HUMAN; MALE; METABOLISM; WORKLOAD;

3-IODOBENZYLGUANIDINE; ADULT; AGED; CHRONIC DISEASE; EXERCISE THERAPY; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEURONS; RADIOPHARMACEUTICALS; VENTRICULAR FUNCTION, LEFT;

EID: 0031896158     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050222     Document Type: Article

References (23)

1. Conn EH, Williams RS, Wallace AG. Exercise responses before and after physical conditioning in patients with severely depressed left ventricular function. Am J Cardiol 1982; 49:296-300.
2. Cobb FR, Williams RS, McEwan P, Jones RH, Coleman RE, Wallace AG. Effects of exercise training on ventricular function in patients with recent myocardial infarction. Circulation 1982;66:100-108.
3. Frick MH, Kalita M. Hemodynamic consequences of physical training after myocardial infarction. Circulation 1968; 37:192-202.
4. Lee AP, Ice R, Blessey R, Sanmarco ME. Long-term effects of physical training on coronary patients with impaired ventricular function. Circulation 1979;60:1519-1526.
5. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction: hemodynamic and metabolic effects. Circulation 1988;78:506-515.
6. Petch MC, Nayler WG. Uptake of catecholamines by human cardiac muscles in vitro. Br Heart J 1979;41:336-339.
7. Bohm M, La Rosee K, Schwinger RHG, Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 1995;25:146-153.
8. Lefkowitz RJ, Caron MG, Stiles GL. Mechanisms of membrane-receptor regulation. N Engl J Med 1994;310:1570-1579.
9. Kline RC, Swanson DP, Wieland DM, Thrall JH, Cross MD, Pitt B. Myocardial imaging in man with I-123 metaiodobenzylguanidine. J Nucl Med 1981;24: 1194-1196.
10. Sisson JC, Wieland DM, Sherman P, Mangner MC, Tobes MC, Jacques S. Metaiodobenzylguanidine as an index of adrenergic nervous system integrity and function. J Nucl Med 1987;28:1620-1624.
11. Tobes MC, Jaques JR, Wieland DM, Sisson JC. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 1985;26:897-907.
12. Schofer J, Spelman R, Schubert A, Weber K, Schluter M. Iodine-123 metaiodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988;12:1252-1258.
13. Merlet P, Valette H, Dubois Randé JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-477.
14. Agostini D, Scanu P, Babatasi G, et al. Pheochromocytoma and catecholamine induced impairment of cardiac neuronal function. Am Heart J 1995;5:1128-1130.
15. 123I-MIBG study. Eur J Nucl Med 1996;23:1037.
16. Coats AJS, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation and autonomic function. Circulation 1992;85:2119-2131.
17. Nakajo M, Shapiro B, Glowniack J, Sisson JC, Beirwaltes WH. Inverse relationship between cardiac accumulation of metaiobenzylguanidine and circulating catecholamines in suspected pheochromocytoma. J Nucl Med 1983;24:1127-1134.
18. Cohn JN, Levine BT, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-823.
19. Merlet P, Dubois Randé JL, Adnot S, et al. Myocardial beta adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic cardiomyopathy. J Cardiovasc Pharmacol 1991;19:10-16.
20. Huguet F, Fagret D, Caillet M, Piriou A, Besnard JC, Guilloteau D. Interaction of metaiodobenzylguanidine with cardioactive drugs: an in vitro study. Eur J Nucl Med 1996;23: 546-549.
21. 123I-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure. Heart 1996;76:218-222.
22. Merlet P, Pouillart P, Dubois-Randé JL, Castaigne A, Syrota A. Improved adrenergic nerve function in human failing heart after beta-blocking therapy. J Nucl Med 1994;35:81P/319.
23. Coats AJS, Adamopoulos S, Meyer TE, Conway J, Sleight P. Effects of physical training in chronic heart failure. Lancet 1990;33:63-66.